Why Chinese Fentanyl Factories Are Making Peptides Now
Chinese chemical manufacturers that previously supplied fentanyl precursors to drug cartels are now pivoting to selling peptides, an unregulated wellness market booming in the U.S. with over $10 million in monthly cryptocurrency purchases. These companies use the same smuggling tactics—mislabeled boxes and customs evasion—to deliver unapproved peptides directly to American consumers.
Summary
The episode examines how Chinese chemical producers, particularly those in the underground market, have shifted their business model from supplying fentanyl precursors to drug cartels to selling peptides as the wellness industry explodes. For nearly a decade, the U.S. government has attempted to crack down on Chinese fentanyl precursor suppliers, which contributed to almost 50,000 synthetic opioid deaths in 2024 alone. Chinese authorities have slowly imposed export controls on precursor producers, threatening companies like Henri Renchen, which was indicted by the U.S. Department of Justice in 2023 for shipping fentanyl precursors to New York. However, Chinese companies face no practical consequences since they operate outside U.S. jurisdiction.
In response to increased scrutiny, approximately 50 out of 200+ fentanyl precursor suppliers have pivoted to peptides, a market driven by American consumers and influencers promoting peptides for anti-aging, weight loss, muscle recovery, and tanning. The peptide market has exploded dramatically—from $200,000 in monthly cryptocurrency purchases before 2025 to over $10 million monthly in 2025. Most peptides sold in this gray market lack FDA approval and scientific validation, yet consumers purchase them directly from Chinese manufacturers rather than through drug cartels, making the business more profitable and safer for suppliers.
These Chinese companies employ identical smuggling methods for peptides as they did for fentanyl precursors: mislabeling shipments (often as snacks), evading customs inspection, and shipping directly to consumers. While U.S. Customs and Border Protection reported over 2,400 seizures of illicit pharmaceuticals from October 2025 through August, many shipments still penetrate U.S. borders. Unlike fentanyl precursors, peptides face minimal Chinese government oversight, creating a regulatory vacuum that enables continued operations. The episode frames this as symptomatic of a wellness industry operating without proper safeguards, where both suppliers and desperate consumers benefit from the unregulated gray market.
About this episode
The world’s biggest chemical industry is in China. For years, Chinese factories have also been a major producer of ingredients used to make fentanyl, the synthetic opioid that has contributed to thousands of deaths in the U.S. After a recent crackdown in China, WSJ’s Patricia Kowsmann reports that some of those same factories are now entering a new booming U.S. market: bootleg peptides. Imani Moise hosts. Further Listening: - Peptides Are Everywhere. Businesses Are Cashing In. - How Cocaine is Flooding in Europe Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
Key Insights
- Chinese fentanyl precursor suppliers faced no practical consequences from U.S. DOJ indictments because they operate outside American jurisdiction, yet Chinese government export controls forced them to find alternative revenue streams.
- The peptide market has grown from $200,000 to over $10 million in monthly cryptocurrency purchases, with at least 50 former fentanyl precursor companies now participating in this less-scrutinized business.
- Selling peptides directly to consumers is more profitable than selling fentanyl precursors to drug cartels because it eliminates middlemen, despite both requiring identical smuggling tactics and mislabeling.
- The FDA has approved only a small fraction of peptides on the market; the vast majority lack approval or scientific validation, yet consumers continue purchasing them through gray market channels.
- Chinese companies use identical smuggling methods for peptides as fentanyl precursors—mislabeled boxes labeled as snacks and customs evasion services—indicating a systematic smuggling infrastructure adapted to new products.
Topics
Transcript
If a chemical exists, there's a good chance that a factory in China can make it and sell it for less than almost anyone else. Now, there are tons of like super legit Chinese chemical producers. That's our colleague Patricia Kaussmann. She's based in Singapore. And then there's like a whole layer of underground ones. So when you say underground, what type of products were they selling? These Chinese chemical producers, they are the big providers of fentanyl ingredients, which of course became a big issue in the US. We are in the midst of the worst drug crisis in U.S. history. The drug is fentanyl. Fentanyl is a highly potent opioid. It's at least 50 times more potent than…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Journal.
Can Xbox Get Back in the Game?
Xbox, once a leader in gaming, has struggled as its Game Pass subscription strategy failed to generate expected revenue and subscriber numbers. New leader Asha Sharma is restructuring the business by cutting costs, reducing Game Pass content, reinstating traditional game sales, and refocusing on flagship franchises rather than Phil Spencer's vision of a service-based model.
Rogue Pilots Are a Growing Safety Threat. No One Knows How to Stop Them.
A Wall Street Journal investigation reveals that rogue pilots intentionally crashing aircraft due to severe mental health issues may be a significant but largely unacknowledged threat to aviation safety. The episode explores documented cases, the aviation industry's reluctance to address the problem, and emerging efforts to improve pilot mental health screening and support.
Red, White and Who? The Anti-AI Voters
AI data centers have emerged as a major election issue in battleground states like Ohio, scrambling traditional political alignments as voters blame whichever party they hold responsible for the facilities. Long-time Republican voter Brandon Bernard is switching his support to Democrats over data center concerns, while politicians from both parties struggle to respond to widespread voter backlash over environmental, utility cost, and transparency issues.
Is Xi Jinping’s Health Declining?
The Journal investigates concerns about Chinese President Xi Jinping's health based on observations during his visits to India and Washington, highlighting how China's lack of transparency and Xi's consolidation of power without a clear successor create potential risks for China and global stability.